메뉴 건너뛰기




Volumn 60, Issue 8, 2011, Pages 1139-1151

Insulin resistance and hepatitis C: An evolving story

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; CORE PROTEIN; INSULIN; INSULIN RECEPTOR; INSULIN SENSITIZING AGENT; METFORMIN; NONSTRUCTURAL PROTEIN 5A; PEGINTERFERON ALPHA2A PLUS RIBAVIRIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PIOGLITAZONE; PLACEBO;

EID: 79960301485     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gut.2010.228262     Document Type: Review
Times cited : (58)

References (167)
  • 1
    • 0035856949 scopus 로고    scopus 로고
    • Insulin signalling and the regulation of glucose and lipid metabolism
    • DOI 10.1038/414799a
    • Saltiel AR, Kahn CR. Insulin signaling and the regulation of glucose and lipid metabolism. Nature 2001;414:799-806. (Pubitemid 34000783)
    • (2001) Nature , vol.414 , Issue.6865 , pp. 799-806
    • Saltiel, A.R.1    Kahn, C.R.2
  • 2
    • 0019762341 scopus 로고
    • The effect of insulin on the disposal of intravenous glucose. Results from indirect calorimetry and hepatic and femoral venous catheterization
    • DeFronzo RA, Jacot E, Jequier E, et al. The effect of insulin on the disposal of intravenous glucose. Results from indirect calorimetry and hepatic and femoral venous catheterization. Diabetes 1981;30:1000-7.
    • (1981) Diabetes , vol.30 , pp. 1000-1007
    • DeFronzo, R.A.1    Jacot, E.2    Jequier, E.3
  • 3
    • 0034804783 scopus 로고    scopus 로고
    • Sterol regulatory element-binding proteins (SREBPs): Transcriptional regulators of lipid synthetic genes
    • DOI 10.1016/S0163-7827(01)00010-8, PII S0163782701000108
    • Shimano H. Sterol regulatory element-binding proteins (SREBPs): transcriptional regulators of lipid synthetic genes. Prog Lipid Res 2001;40:439-52. (Pubitemid 32929966)
    • (2001) Progress in Lipid Research , vol.40 , Issue.6 , pp. 439-452
    • Shimano, H.1
  • 4
    • 0344305782 scopus 로고    scopus 로고
    • Insulin Signaling in Health and Disease
    • DOI 10.1126/science.1092952
    • White MF. Insulin signaling in health and disease. Science 2003;302:1710-11. (Pubitemid 37505726)
    • (2003) Science , vol.302 , Issue.5651 , pp. 1710-1711
    • White, M.F.1
  • 5
    • 0034874559 scopus 로고    scopus 로고
    • Insulin receptor substrate proteins and neuroendocrine function
    • DOI 10.1042/BST0290525
    • Withers DJ. Insulin receptor substrate proteins and neuroendocrine function. Biochem Soc Trans 2001;29:525-9. (Pubitemid 32783650)
    • (2001) Biochemical Society Transactions , vol.29 , Issue.4 , pp. 525-529
    • Withers, D.J.1
  • 7
    • 33749431713 scopus 로고    scopus 로고
    • The mTOR pathway in the control of protein synthesis
    • DOI 10.1152/physiol.00024.2006
    • Wang X, Proud CG. The mTOR pathway in the control of protein synthesis. Physiology (Bethesda) 2006;21:362-9. (Pubitemid 44511764)
    • (2006) Physiology , vol.21 , Issue.5 , pp. 362-369
    • Wang, X.1    Proud, C.G.2
  • 8
    • 0033664539 scopus 로고    scopus 로고
    • Insulin receptors and insulin action in the brain: Review and clinical implications
    • Schulingkamp RJ, Pagano TC, Hung D, et al. Insulin receptors and insulin action in the brain: review and clinical implications. Neurosci Biobehav Rev 2000;24:855-72.
    • (2000) Neurosci Biobehav Rev , vol.24 , pp. 855-872
    • Schulingkamp, R.J.1    Pagano, T.C.2    Hung, D.3
  • 9
    • 0027184568 scopus 로고
    • Molecular dynamics of insulin/ IGF-I receptor transmembrane signaling
    • discussion 344-35
    • Pessin JE, Frattali AL. Molecular dynamics of insulin/ IGF-I receptor transmembrane signaling. Mol Reprod Dev 1993;35:339-4; discussion 344-35.
    • (1993) Mol Reprod Dev , vol.35 , pp. 339-344
    • Pessin, J.E.1    Frattali, A.L.2
  • 10
    • 77953481679 scopus 로고    scopus 로고
    • Association of circulating insulin-like growth factor 1 with hepatocellular carcinoma: One cross-sectional correlation study
    • Su WW, Lee KT, Yeh YT, et al. Association of circulating insulin-like growth factor 1 with hepatocellular carcinoma: one cross-sectional correlation study. J Clin Lab Anal 2010;24:195-200.
    • (2010) J Clin Lab Anal , vol.24 , pp. 195-200
    • Su, W.W.1    Lee, K.T.2    Yeh, Y.T.3
  • 11
    • 42449087698 scopus 로고    scopus 로고
    • The GHeIGF1 axis and longevity. The paradigm of IGF1 deficiency
    • Laron Z. The GHeIGF1 axis and longevity. The paradigm of IGF1 deficiency. Hormones (Athens) 2008;7:24-7.
    • (2008) Hormones (Athens) , vol.7 , pp. 24-27
    • Laron, Z.1
  • 12
    • 0033984997 scopus 로고    scopus 로고
    • Relationship between several surrogate estimates of insulin resistance and quantification of insulin-mediated glucose disposal in 490 healthy nondiabetic volunteers
    • Yeni-Komshian H, Carantoni M, Abbasi F, et al. Relationship between several surrogate estimates of insulin resistance and quantification of insulin mediated glucose disposal in 490 healthy, nondiabetic volunteers. Diabetes Care 2000;23:171-5. (Pubitemid 30071019)
    • (2000) Diabetes Care , vol.23 , Issue.2 , pp. 171-175
    • Yeni-Komshian, H.1    Carantoni, M.2    Abbasi, F.3    Reaven, G.M.4
  • 13
    • 0018237942 scopus 로고
    • Insulin resistance, insulin insensitivity, and insulin unresponsiveness: A necessary distinction
    • Kahn CR. Insulin resistance, insulin insensitivity, and insulin unresponsiveness: a necessary distinction. Metabolism 1978;27:1893-902. (Pubitemid 9082246)
    • (1978) Metabolism: Clinical and Experimental , vol.27 , Issue.12 SUPPL. 2 , pp. 1893-1902
    • Kahn, C.R.1
  • 14
    • 1842452946 scopus 로고    scopus 로고
    • Gene variants, insulin resistance, and dyslipidaemia
    • DOI 10.1097/00041433-200404000-00004
    • Laakso M. Gene variants, insulin resistance and dyslipidemia. Curr Opin Lipidol 2004;15:115-20. (Pubitemid 38453399)
    • (2004) Current Opinion in Lipidology , vol.15 , Issue.2 , pp. 115-120
    • Laakso, M.1
  • 17
    • 0029893417 scopus 로고    scopus 로고
    • A common aminoacid polymorphism in insulin receptor substrate-1 causes impaired insulin signalling. Evidence from transfection studies
    • Almind K, Inoue G, Pedersen O, et al. A common aminoacid polymorphism in insulin receptor substrate-1 causes impaired insulin signalling. Evidence from transfection studies. J Clin Invest 1996;97:2569-75.
    • (1996) J Clin Invest , vol.97 , pp. 2569-2575
    • Almind, K.1    Inoue, G.2    Pedersen, O.3
  • 21
    • 0034751858 scopus 로고    scopus 로고
    • Serine phosphorylation of insulin receptor substrate-1: A novel target for the reversal of insulin resistance
    • DOI 10.1210/me.15.11.1864
    • Sykiotis GP, Papavassiliou AG. Serine phosphorylation of insulin receptor substrate-1: a novel target for the reversal of insulin resistance. Mol Endocrinol 2001;15:1864-9. (Pubitemid 33022527)
    • (2001) Molecular Endocrinology , vol.15 , Issue.11 , pp. 1864-1869
    • Sykiotis, G.P.1    Papavassiliou, A.G.2
  • 22
    • 0042570843 scopus 로고    scopus 로고
    • Protein-protein interaction in insulin signaling and the molecular mechanisms of insulin resistance
    • Virkamäki A, Ueki K, Kahn CR. Proteineprotein interaction in insulin signaling and the molecular mechanisms of insulin resistance. J Clin Invest 1999;103:931-43. (Pubitemid 29169600)
    • (1999) Journal of Clinical Investigation , vol.103 , Issue.7 , pp. 931-943
    • Virkamaki, A.1    Ueki, K.2    Kahn, C.R.3
  • 23
    • 14644426519 scopus 로고    scopus 로고
    • Complementary roles of IRS-1 and IRS-2 in the hepatic regulation of metabolism
    • DOI 10.1172/JCI200523187
    • Taniguchi CM, Ueki K, Kahn R. Complementary roles of IRS-1 and IRS-2 in the hepatic regulation of metabolism. J Clin Invest 2005;115:718-27. (Pubitemid 40322247)
    • (2005) Journal of Clinical Investigation , vol.115 , Issue.3 , pp. 718-727
    • Taniguchi, C.M.1    Ueki, K.2    Kahn, C.R.3
  • 24
    • 0037065523 scopus 로고    scopus 로고
    • Association between hepatitis C virus seropositivity, carotid-artery plaque, and intima-media thickening
    • DOI 10.1016/S0140-6736(02)07339-7
    • Ishizaka N, Ishizaka Y, Takahashi E, et al. Association between hepatitis C virus seropositivity, carotid-artery plaque, and intimamedia thickening. Lancet 2002;359:133-5. (Pubitemid 34112545)
    • (2002) Lancet , vol.359 , Issue.9301 , pp. 133-135
    • Ishizaka, N.1    Ishizaka, Y.2    Takahashi, E.3    Tooda, E.-I.4    Hashimoto, H.5    Nagai, R.6    Yamakado, M.7
  • 25
    • 0028618516 scopus 로고
    • Evidence for a link between hepatitis C virus infection and diabetes mellitus in a cirrhotic population
    • Allison ME, Wreghitt T, Palmer CR, et al. Evidence for a link between hepatitis C virus infection and diabetes mellitus in a cirrhotic population. J Hepatol 1994;21:1135-9.
    • (1994) J Hepatol , vol.21 , pp. 1135-1139
    • Allison, M.E.1    Wreghitt, T.2    Palmer, C.R.3
  • 29
    • 0033983645 scopus 로고    scopus 로고
    • Prevalence of diabetes mellitus in patients with end-stage liver cirrhosis due to hepatitis C, alcohol, or cholestatic disease
    • Zein NN, Abdulkarim AS, Wiesner RH, et al. Prevalence of diabetes mellitus in patients with end stage liver cirrhosis due to hepatitis C, alcohol, or cholestatic disease. J Hepatol 2000;32:209-17. (Pubitemid 30093899)
    • (2000) Journal of Hepatology , vol.32 , Issue.2 , pp. 209-217
    • Zein, N.N.1    Abdulkarim, A.S.2    Wiesner, R.H.3    Egan, K.S.4    Persing, D.H.5
  • 30
    • 0037846082 scopus 로고    scopus 로고
    • Association of hepatitis C infection and antiretroviral use with diabetes mellitus in drug users
    • DOI 10.1086/374838
    • Howard AA, Klein RS, Schoenbaum EE. Association of hepatitis C infection and antiretroviral use with diabetes mellitus in drug users. Clin Infect Dis 2003;36:1318-23. (Pubitemid 36629943)
    • (2003) Clinical Infectious Diseases , vol.36 , Issue.10 , pp. 1318-1323
    • Howard, A.A.1    Klein, R.S.2    Schoenbaum, E.E.3
  • 31
    • 2342586877 scopus 로고    scopus 로고
    • High Prevalence of Glucose Abnormalities in Patients with Hepatitis C Virus Infection: A multivariate analysis considering the liver injury
    • DOI 10.2337/diacare.27.5.1171
    • Lecube A, Hernández C, Genescà J, et al. High prevalence of glucose abnormalities in patients with hepatitis C virus infection: a multivariate analysis considering the liver injury. Diabetes Care 2004;27:1171-5. (Pubitemid 38579785)
    • (2004) Diabetes Care , vol.27 , Issue.5 , pp. 1171-1175
    • Lecube, A.1    Hernandez, C.2    Genesca, J.3    Esteban, J.I.4    Jardi, R.5    Simo, R.6
  • 32
    • 34249097401 scopus 로고    scopus 로고
    • Hepatitis C viremia increases the association with type 2 diabetes mellitus in a hepatitis B and C endemic area: An epidemiological link with virological implication
    • Huang JF, Dai CY, Hwang SJ, et al. Hepatitis C viremia increases the association with type 2 diabetes mellitus in a hepatitis B and C endemic area: an epidemiological link with virological implication. Am J Gastroenterol 2007;102:1237-43.
    • (2007) Am J Gastroenterol , vol.102 , pp. 1237-1243
    • Huang, J.F.1    Dai, C.Y.2    Hwang, S.J.3
  • 33
    • 39549103662 scopus 로고    scopus 로고
    • Prevalence of diabetes mellitus and insulin resistance in patients with chronic hepatitis C: Comparison with hepatitis B virus-infected and hepatitis C virus-cleared patients
    • DOI 10.1111/j.1478-3231.2007.01630.x
    • Imazeki F, Yokosuka O, Fukai K, et al. Prevalence of diabetes mellitus and insulin resistance in patients with chronic hepatitis C: comparison with hepatitis B virus-infected and hepatitis C virus-cleared patients. Liver Int 2008;28:355-62. (Pubitemid 351279583)
    • (2008) Liver International , vol.28 , Issue.3 , pp. 355-362
    • Imazeki, F.1    Yokosuka, O.2    Fukai, K.3    Kanda, T.4    Kojima, H.5    Saisho, H.6
  • 34
    • 0028985869 scopus 로고
    • High prevalence of hepatitis C infection in Afro-Caribbean patients with type 2 diabetes and abnormal liver function tests
    • ray H, Wreghitt T, Stratton IM, et al. High prevalence of hepatitis C infection in Afro-Caribbean patients with type 2 diabetes and abnormal liver function tests. Diabet Med 1995;12:244-9.
    • (1995) Diabet Med , vol.12 , pp. 244-249
    • Ray, H.1    Wreghitt, T.2    Stratton, I.M.3
  • 35
    • 0029739641 scopus 로고    scopus 로고
    • High prevalence of hepatitis C virus infection in diabetic patients
    • Simó R, Hernández C, Genescá J, et al. High prevalence of hepatitis C virus infection in diabetic patients. Diabetes Care 1996;19:998-1000.
    • (1996) Diabetes Care , vol.19 , pp. 998-1000
    • Simó, R.1    Hernández, C.2    Genescá, J.3
  • 36
    • 0032708038 scopus 로고    scopus 로고
    • Low prevalence of hepatitis C virus infection in Greek diabetic patients
    • Sotiropoulos A, Peppas TA, Skliros E, et al. Low prevalence of hepatitis C virus infection in Greek diabetic patients. Diabet Med 1999;16:250-2.
    • (1999) Diabet Med , vol.16 , pp. 250-252
    • Sotiropoulos, A.1    Peppas, T.A.2    Skliros, E.3
  • 38
    • 0141834921 scopus 로고    scopus 로고
    • Is diabetes mellitus a risk factor for HCV infection?
    • Picerno I, Di Pietro A, Spataro P, et al. Is diabetes mellitus a risk factor for HCV infection? Ann Ig 2002;14:473-7.
    • (2002) Ann Ig , vol.14 , pp. 473-477
    • Picerno, I.1    Di Pietro, A.2    Spataro, P.3
  • 42
    • 33646253204 scopus 로고    scopus 로고
    • Seroprevalence of hepatitis B and C in type 2 diabetic patients
    • Chen HF, Li CY, Chen P, et al. Seroprevalence of hepatitis B and C in type 2 diabetic patients. J Chin Med Assoc 2006;69:146-52.
    • (2006) J Chin Med Assoc , vol.69 , pp. 146-152
    • Chen, H.F.1    Li, C.Y.2    Chen, P.3
  • 43
    • 53449088491 scopus 로고    scopus 로고
    • Evaluation of risk factors and seroprevalence of hepatitis B and C in diabetic patients in Kutahya, Turkey
    • Gulcan A, Gulcan E, Toker A, et al. Evaluation of risk factors and seroprevalence of hepatitis B and C in diabetic patients in Kutahya, Turkey. J Investig Med 2008;56:858-63.
    • (2008) J Investig Med , vol.56 , pp. 858-863
    • Gulcan, A.1    Gulcan, E.2    Toker, A.3
  • 44
    • 0033779703 scopus 로고    scopus 로고
    • Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States
    • Mehta SH, Brancati FL, Sulkowski MS, et al. Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States. Ann Intern Med 2000;133:592-9.
    • (2000) Ann Intern Med , vol.133 , pp. 592-599
    • Mehta, S.H.1    Brancati, F.L.2    Sulkowski, M.S.3
  • 45
    • 53249121480 scopus 로고    scopus 로고
    • Hepatitis C infection and risk of diabetes: A systematic review and meta-analysis
    • White DL, Ratziu V, El-Serag HB. Hepatitis C infection and risk of diabetes: a systematic review and meta-analysis. J Hepatol 2008;49:831-44.
    • (2008) J Hepatol , vol.49 , pp. 831-844
    • White, D.L.1    Ratziu, V.2    El-Serag, H.B.3
  • 48
    • 30644477347 scopus 로고    scopus 로고
    • Chronic hepatitis C virus infection and post-liver transplantation diabetes mellitus
    • Ma Y, Yan WW. Chronic hepatitis C virus infection and post liver transplantation diabetes mellitus. World J Gastroenterol 2005;11:6085-9. (Pubitemid 43085046)
    • (2005) World Journal of Gastroenterology , vol.11 , Issue.39 , pp. 6085-6089
    • Ma, Y.1    Yan, W.-W.2
  • 52
    • 2942679145 scopus 로고    scopus 로고
    • Is hepatitis C a risk factor to post transplant diabetes mellitus after renal transplantation in patients using tacrolimus?
    • Finni PE, Souza ER, Rioja S, et al. Is hepatitis C a risk factor to post transplant diabetes mellitus after renal transplantation in patients using tacrolimus? Transplant Proc 2004;36:884-5.
    • (2004) Transplant Proc , vol.36 , pp. 884-885
    • Finni, P.E.1    Souza, E.R.2    Rioja, S.3
  • 53
    • 33845935691 scopus 로고    scopus 로고
    • Risk factors for development of new-onset diabetes mellitus after kidney transplantation
    • DOI 10.1097/01.tp.0000250756.66348.9a, PII 0000789020061227000029
    • Shah T, Kasravi A, Huang E, et al. Risk factors for development of new-onset diabetes mellitus after kidney transplantation. Transplantation 2006;82:1673-6. (Pubitemid 46035650)
    • (2006) Transplantation , vol.82 , Issue.12 , pp. 1673-1676
    • Shah, T.1    Kasravi, A.2    Huang, E.3    Hayashi, R.4    Young, B.5    Cho, Y.W.6    Bunnapradist, S.7
  • 55
    • 55249084386 scopus 로고    scopus 로고
    • Hepatitis C virus infection and post-transplant diabetes mellitus among renal transplant patients: A meta-analysis
    • Fabrizi F, Messa P, Martin P, et al. Hepatitis C virus infection and post-transplant diabetes mellitus among renal transplant patients: a meta-analysis. Int J Artif Organs 2008;31:675-82.
    • (2008) Int J Artif Organs , vol.31 , pp. 675-682
    • Fabrizi, F.1    Messa, P.2    Martin, P.3
  • 56
  • 59
    • 33646590958 scopus 로고    scopus 로고
    • Correlation between insulin resistance and hepatitis C viral load
    • author reply 1168-1169
    • Harrison SA. Correlation between insulin resistance and hepatitis C viral load. Hepatology 2006;43:1168; author reply 1168-1169.
    • (2006) Hepatology , vol.43 , pp. 1168
    • Harrison, S.A.1
  • 60
    • 84984570561 scopus 로고    scopus 로고
    • High hepatitis C viral load is associated with insulin resistance in patients with chronic hepatitis C
    • Hsu CS, Liu CJ, Liu CH, et al. High hepatitis C viral load is associated with insulin resistance in patients with chronic hepatitis C. Liver Int 2008;28:271-7.
    • (2008) Liver Int , vol.28 , pp. 271-277
    • Hsu, C.S.1    Liu, C.J.2    Liu, C.H.3
  • 62
    • 58549092990 scopus 로고    scopus 로고
    • Risk factors for the development of diabetes mellitus in chronic hepatitis C virus genotype 4 infection
    • Chehadeh W, Abdella N, Ben-Nakhi A, et al. Risk factors for the development of diabetes mellitus in chronic hepatitis C virus genotype 4 infection. J Gastroenterol Hepatol 2009;24:42-8.
    • (2009) J Gastroenterol Hepatol , vol.24 , pp. 42-48
    • Chehadeh, W.1    Abdella, N.2    Ben-Nakhi, A.3
  • 63
    • 40949151098 scopus 로고    scopus 로고
    • Effect of sustained virological response to treatment on the incidence of abnormal glucose values in chronic hepatitis C
    • Romero-Gómez M, Fernández-Rodríguez CM, Andrade RJ, et al. Effect of sustained virological response to treatment on the incidence of abnormal glucose values in chronic hepatitis C. J Hepatol 2008;48:721-7.
    • (2008) J Hepatol , vol.48 , pp. 721-727
    • Romero-Gómez, M.1    Fernández-Rodríguez, C.M.2    Andrade, R.J.3
  • 64
    • 53149087822 scopus 로고    scopus 로고
    • Incidence of type 2 diabetes mellitus and glucose abnormalities in patients with chronic hepatitis C infection by response to treatment: Results of a cohort study
    • Giordanino C, Bugianesi E, Smedile A, et al. Incidence of type 2 diabetes mellitus and glucose abnormalities in patients with chronic hepatitis C infection by response to treatment: results of a cohort study. Am J Gastroenterol 2008;103:2481-7.
    • (2008) Am J Gastroenterol , vol.103 , pp. 2481-2487
    • Giordanino, C.1    Bugianesi, E.2    Smedile, A.3
  • 65
    • 63349097919 scopus 로고    scopus 로고
    • Sustained virological response reduces incidence of onset of type 2 diabetes in chronic hepatitis C
    • Arase Y, Suzuki F, Suzuki Y, et al. Sustained virological response reduces incidence of onset of type 2 diabetes in chronic hepatitis C. Hepatology 2009;49:739-44.
    • (2009) Hepatology , vol.49 , pp. 739-744
    • Arase, Y.1    Suzuki, F.2    Suzuki, Y.3
  • 66
    • 33845866857 scopus 로고    scopus 로고
    • Inflammation and metabolic disorders
    • DOI 10.1038/nature05485, PII NATURE05485
    • Hotamisligil GS. Inflammation and metabolic disorders. Nature 2006;444:860-7. (Pubitemid 46024993)
    • (2006) Nature , vol.444 , Issue.7121 , pp. 860-867
    • Hotamisligil, G.S.1
  • 67
    • 46249111657 scopus 로고    scopus 로고
    • Hepatitis C virus infection: Molecular pathways to metabolic syndrome
    • DOI 10.1002/hep.22269
    • Sheikh MY, Choi J, Qadri I, et al. Hepatitis C virus infection: molecular pathways to metabolic syndrome. Hepatology 2008;47:2127-33. (Pubitemid 351945577)
    • (2008) Hepatology , vol.47 , Issue.6 , pp. 2127-2133
    • Sheikh, M.Y.1    Choi, J.2    Qadri, I.3    Friedman, J.E.4    Sanyal, A.J.5
  • 68
    • 1542287381 scopus 로고    scopus 로고
    • Hepatitis C Virus Infection and Diabetes: Direct Involvement of the Virus in the Development of Insulin Resistance
    • DOI 10.1053/j.gastro.2003.11.056
    • Shintani Y, Fujie H, Miyoshi H, et al. Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance. Gastroenterology 2004;126:840-8. (Pubitemid 38298332)
    • (2004) Gastroenterology , vol.126 , Issue.3 , pp. 840-848
    • Shintani, Y.1    Fujie, H.2    Miyoshi, H.3    Tsutsumi, T.4    Tsukamoto, K.5    Kimura, S.6    Moriya, K.7    Koike, K.8
  • 69
    • 0034121558 scopus 로고    scopus 로고
    • Increases in intrahepatic CD68 positive cells, MAC387 positive cells, and proinflammatory cytokines (particularly interleukin 18) in chronic hepatitis C infection
    • McGuinness PH, Painter D, Davies S, et al. Increases in intrahepatic CD68 positive cells, MAC387 positive cells, and proinflammatory cytokines (particularly interleukin 18) in chronic hepatitis C infection. Gut 2000;46:260-9.
    • (2000) Gut , vol.46 , pp. 260-269
    • McGuinness, P.H.1    Painter, D.2    Davies, S.3
  • 70
    • 34248578773 scopus 로고    scopus 로고
    • Regulation of glucose transporter type 4-isoform-gene expression in muscle and adipocytes
    • Im SS, Kwon SK, Kim TH, et al. Regulation of glucose transporter type 4-isoform-gene expression in muscle and adipocytes. IUBMB Life 2007;59:134-45.
    • (2007) IUBMB Life , vol.59 , pp. 134-145
    • Im, S.S.1    Kwon, S.K.2    Kim, T.H.3
  • 73
    • 34547444610 scopus 로고    scopus 로고
    • Insulin resistance and liver injury in hepatitis C is not associated with virus-specific changes in adipocytokines
    • DOI 10.1002/hep.21703
    • Cua IH, Hui JM, Bandara P, et al. Insulin resistance and liver injury in hepatitis C is not associated with virus-specific changes in adipocytokines. Hepatology 2007;46:66-73. (Pubitemid 47171922)
    • (2007) Hepatology , vol.46 , Issue.1 , pp. 66-73
    • Cua, I.H.Y.1    Hui, J.M.2    Bandara, P.3    Kench, J.G.4    Farrell, G.C.5    McCaughan, G.W.6    George, J.7
  • 74
    • 62749155010 scopus 로고    scopus 로고
    • Hepatitis C virus and glucose and lipid metabolism
    • Alaei M, Negro F. Hepatitis C virus and glucose and lipid metabolism. Diabetes Metab 2008;34:692-700.
    • (2008) Diabetes Metab , vol.34 , pp. 692-700
    • Alaei, M.1    Negro, F.2
  • 76
    • 0345017776 scopus 로고    scopus 로고
    • Impaired IRS-1/PI3-Kinase Signaling in Patients with HCV: A Mechanism for Increased Prevalence of Type 2 Diabetes
    • DOI 10.1016/j.hep.2003.09.012
    • Aytug S, Reich D, Sapiro LE, et al. Impaired IRS-1/PI3-kinase signaling in patients with HCV: a mechanism for increased prevalence of type 2 diabetes. Hepatology 2003;38:1384-92. (Pubitemid 37466964)
    • (2003) Hepatology , vol.38 , Issue.6 , pp. 1384-1392
    • Aytug, S.1    Reich, D.2    Sapiro, L.E.3    Bernstein, D.4    Begum, N.5
  • 78
    • 40149089262 scopus 로고    scopus 로고
    • Hepatitis C virus core protein upregulates serine phosphorylation of insulin receptor substrate-1 and impairs the downstream Akt/protein kinase B signaling pathway for insulin resistance
    • DOI 10.1128/JVI.01672-07
    • Banerjee S, Saito K, Ait-Goughoulte M, et al. Hepatitis C virus core protein upregulates serine phosphorylation of insulin receptor substrate-1 and impairs the downstream akt/protein kinase B signaling pathway for insulin resistance. J Virol 2008;82:2606-12. (Pubitemid 351329151)
    • (2008) Journal of Virology , vol.82 , Issue.6 , pp. 2606-2612
    • Banerjee, S.1    Saito, K.2    Ait-Goughoulte, M.3    Meyer, K.4    Ray, R.B.5    Ray, R.6
  • 79
    • 34248671715 scopus 로고    scopus 로고
    • The hepatitis C virus core protein of genotypes 3a and 1b downregulates insulin receptor substrate 1 through genotype-specific mechanisms
    • DOI 10.1002/hep.21634
    • Pazienza V, Clément S, Pugnale P, et al. The hepatitis C virus core protein of genotypes 3a and 1b downregulates insulin receptor substrate 1 through genotype-specific mechanisms. Hepatology 2007;45:1164-71. (Pubitemid 46775778)
    • (2007) Hepatology , vol.45 , Issue.5 , pp. 1164-1171
    • Pazienza, V.1    Clement, S.2    Pugnale, P.3    Conzelman, S.4    Foti, M.5    Mangia, A.6    Negro, F.7
  • 80
    • 27844604269 scopus 로고    scopus 로고
    • Hepatitis C virus core protein inhibits mitochondrial electron transport and increases reactive oxygen species (ROS) production
    • DOI 10.1074/jbc.M506412200
    • Korenaga M, Wang T, Li Y, et al. Hepatitis C virus core protein inhibits mitochondrial electron transport and increases ROS production. J Biol Chem 2005;280:37481-8. (Pubitemid 41642356)
    • (2005) Journal of Biological Chemistry , vol.280 , Issue.45 , pp. 37481-37488
    • Korenaga, M.1    Wang, T.2    Li, Y.3    Showalter, L.A.4    Chan, T.5    Sun, J.6    Weinman, S.A.7
  • 81
    • 33745797050 scopus 로고    scopus 로고
    • Hepatitis C virus triggers mitochondrial permeability transition with production of reactive oxygen species, leading to DNA damage and STATS activation
    • DOI 10.1128/JVI.00321-06
    • Machida K, Cheng KT, Lai CK, et al. Hepatitis C virus triggers mitochondrial permeability transition with production of reactive oxygen species, leading to DNA damage and STAT3 activation. J Virol 2006;80:7199-207. (Pubitemid 44025216)
    • (2006) Journal of Virology , vol.80 , Issue.14 , pp. 7199-7207
    • Machida, K.1    Cheng, K.T.-H.2    Lai, C.-K.3    Jeng, K.-S.4    Sung, V.M.-H.5    Lai, M.M.C.6
  • 83
    • 41149095973 scopus 로고    scopus 로고
    • Elevated expression and polymorphisms of SOCS3 influence patient response to antiviral therapy in chronic hepatitis C
    • DOI 10.1136/gut.2007.129478
    • Persico M, Capasso M, Russo R, et al. Elevated expression and polymorphisms of SOCS3 influence patient response to antiviral therapy in chronic hepatitis C. Gut 2008;57:507-15. (Pubitemid 351442535)
    • (2008) Gut , vol.57 , Issue.4 , pp. 507-515
    • Persico, M.1    Capasso, M.2    Russo, R.3    Persico, E.4    Croce, L.5    Tiribelli, C.6    Iolascon, A.7
  • 86
    • 77952708205 scopus 로고    scopus 로고
    • Hepatitis C virus differentially modulates activation of forkhead transcription factors and insulin-induced metabolic gene expression
    • Banerjee A, Meyer K, Mazumdar B, et al. Hepatitis C virus differentially modulates activation of forkhead transcription factors and insulin-induced metabolic gene expression. J Virol 2010;84:5936-46.
    • (2010) J Virol , vol.84 , pp. 5936-5946
    • Banerjee, A.1    Meyer, K.2    Mazumdar, B.3
  • 87
    • 0036314483 scopus 로고    scopus 로고
    • Hepatitis C virus subgenomic replicons induce endoplasmic reticulum stress activating an intracellular signaling pathway
    • DOI 10.1128/JVI.76.15.7453-7459.2002
    • Tardif KD, Mori K, Siddiqui A. Hepatitis C virus subgenomic replicons induce endoplasmic reticulum stress activating an intracellular signaling pathway. J Virol 2002;76:7453-9. (Pubitemid 34760967)
    • (2002) Journal of Virology , vol.76 , Issue.15 , pp. 7453-7459
    • Tardif, K.D.1    Mori, K.2    Siddiqui, A.3
  • 90
    • 33746134804 scopus 로고    scopus 로고
    • The protein phosphatase 2A represents a novel cellular target for hepatitis C virus NS5A protein
    • DOI 10.1016/j.biochi.2005.12.003, PII S0300908405002774
    • Georgopoulou U, Tsitoura P, Kalamvoki M, et al. The protein phosphatase 2A represents a novel cellular target for hepatitis C virus NS5A protein. Biochimie 2006;88:651-62. (Pubitemid 44081829)
    • (2006) Biochimie , vol.88 , Issue.6 , pp. 651-662
    • Georgopoulou, U.1    Tsitoura, P.2    Kalamvoki, M.3    Mavromara, P.4
  • 91
    • 34548304715 scopus 로고    scopus 로고
    • Activation of endoplasmic reticulum stress response by hepatitis viruses up-regulates protein phosphatase 2A
    • DOI 10.1002/hep.21611
    • Christen V, Treves S, Duong FH, et al. Activation of endoplasmic reticulum stress response by hepatitis viruses up-regulates protein phosphatase 2A. Hepatology 2007;46:558-65. (Pubitemid 47344792)
    • (2007) Hepatology , vol.46 , Issue.2 , pp. 558-565
    • Christen, V.1    Treves, S.2    Duong, F.H.T.3    Heim, M.H.4
  • 92
    • 48449100910 scopus 로고    scopus 로고
    • Virus-induced overexpression of protein phosphatase 2A inhibits insulin signalling in chronic hepatitis C
    • Bernsmeier C, Duong FH, Christen V, et al. Virus-induced overexpression of protein phosphatase 2A inhibits insulin signalling in chronic hepatitis C. J Hepatol 2008;49:429-40.
    • (2008) J Hepatol , vol.49 , pp. 429-440
    • Bernsmeier, C.1    Duong, F.H.2    Christen, V.3
  • 93
    • 0346100572 scopus 로고    scopus 로고
    • Hepatitis C virus inhibits interferon signaling through up-regulation of protein phosphatase 2A
    • Duong FH, Filipowicz M, Tripodi M, et al. Hepatitis C virus inhibits interferon signaling through up-regulation of protein phosphatase 2A. Gastroenterology 2004;126:263-27.
    • (2004) Gastroenterology , vol.126 , pp. 263-327
    • Duong, F.H.1    Filipowicz, M.2    Tripodi, M.3
  • 94
    • 0035933837 scopus 로고    scopus 로고
    • Nonstructural 3 protein of hepatitis C virus triggers an oxidative burst in human monocytes via activation of NADPH oxidase
    • Bureau C, Bernad J, Chaouche N, et al. Nonstructural 3 protein of hepatitis C virus triggers an oxidative burst in human monocytes via activation of NADPH oxidase. J Biol Chem 2001;276:23077-83.
    • (2001) J Biol Chem , vol.276 , pp. 23077-23083
    • Bureau, C.1    Bernad, J.2    Chaouche, N.3
  • 95
    • 0033305213 scopus 로고    scopus 로고
    • Peroxisome proliferator-activated receptors: Nuclear control of metabolism
    • Desvergne B, Wahli W. Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr Rev 1999;20:649-88. (Pubitemid 30650602)
    • (1999) Endocrine Reviews , vol.20 , Issue.5 , pp. 649-688
    • Desvergne, B.1    Wahli, W.2
  • 96
    • 0027161015 scopus 로고
    • PPAR-RXR heterodimer activates a peroxisome proliferator response element upstream of the bifunctional enzyme gene
    • DOI 10.1006/bbrc.1993.1378
    • Bardot O, Aldridge TC, Latruffe N, et al. PPAReRXR heterodimer activates a peroxisome proliferator response element upstream of the bifunctional enzyme gene. Biochem Biophys Res Commun 1993;192:37-45. (Pubitemid 23205265)
    • (1993) Biochemical and Biophysical Research Communications , vol.192 , Issue.1 , pp. 37-45
    • Bardot, O.1    Aldridge, T.C.2    Latruffe, N.3    Green, S.4
  • 98
    • 0033574663 scopus 로고    scopus 로고
    • A unified nomenclature system for the nuclear receptor superfamily
    • Nuclear Receptors Nomenclature Committee
    • Nuclear Receptors Nomenclature Committee. A unified nomenclature system for the nuclear receptor superfamily. Cell 1999;97:161-3.
    • (1999) Cell , vol.97 , pp. 161-163
  • 101
    • 38849184816 scopus 로고    scopus 로고
    • PPARalpha activation is essential for HCV core protein-induced hepatic steatosis and hepatocellular carcinoma in mice
    • DOI 10.1172/JCI33594
    • Tanaka N, Moriya K, Kiyosawa K, et al. PPAR alpha activation is essential for HCV core protein-induced hepatic steatosis and hepatocellular carcinoma in mice. J Clin Invest 2008;118:683-94. (Pubitemid 351206557)
    • (2008) Journal of Clinical Investigation , vol.118 , Issue.2 , pp. 683-694
    • Tanaka, N.1    Moriya, K.2    Kiyosawa, K.3    Koike, K.4    Gonzalez, F.J.5    Aoyama, T.6
  • 102
    • 1942534687 scopus 로고    scopus 로고
    • Adiponectin and Its Role in the Obesity-Induced Insulin Resistance and Related Complications
    • Haluzik M, Parizkova J, Haluzik MM. Adiponectin and its role in the obesity-induced insulin resistance and related complications. Physiol Res 2004;53:123-29. (Pubitemid 38525115)
    • (2004) Physiological Research , vol.53 , Issue.2 , pp. 123-129
    • Haluzik, M.1    Parizkova, J.2    Haluzik, M.M.3
  • 103
    • 21744438136 scopus 로고    scopus 로고
    • Hepatitis C virus-core and non structural proteins lead to different effects on cellular antioxidant defenses
    • Abdalla MY, Ahmad IM, Spitz DR, et al. Hepatitis C virus-core and non structural proteins lead to different effects on cellular antioxidant defenses. J Med Virol 2005;76:489-7.
    • (2005) J Med Virol , vol.76 , pp. 489-497
    • Abdalla, M.Y.1    Ahmad, I.M.2    Spitz, D.R.3
  • 105
    • 0036165333 scopus 로고    scopus 로고
    • Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein
    • Okuda M, Li K, Beard MR, et al. Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein. Gastroenterology 2002;122:366-75. (Pubitemid 34116988)
    • (2002) Gastroenterology , vol.122 , Issue.2 , pp. 366-375
    • Okuda, M.1    Li, K.2    Beard, M.R.3    Showalter, L.A.4    Scholle, F.5    Lemon, S.M.6    Weinman, S.A.7
  • 106
    • 70449653438 scopus 로고    scopus 로고
    • Insulin resistance and not steatosis is associated with modifications in oxidative stress markers in chronic hepatitis C, non-3 genotype
    • Oliveira AC, Parise ER, Catarino RM, et al. Insulin resistance and not steatosis is associated with modifications in oxidative stress markers in chronic hepatitis C, non-3 genotype. Free Radic Res 2009;43:1187-94.
    • (2009) Free Radic Res , vol.43 , pp. 1187-1194
    • Oliveira, A.C.1    Parise, E.R.2    Catarino, R.M.3
  • 107
    • 39149097142 scopus 로고    scopus 로고
    • Interplay between oxidative stress and hepatic steatosis in the progression of chronic hepatitis C
    • Vidali M, Tripodi MF, Ivaldi A, et al. Interplay between oxidative stress and hepatic steatosis in the progression of chronic hepatitis C. J Hepatol 2008;48:399-406.
    • (2008) J Hepatol , vol.48 , pp. 399-406
    • Vidali, M.1    Tripodi, M.F.2    Ivaldi, A.3
  • 108
    • 33746658598 scopus 로고    scopus 로고
    • Oxidative stress and antioxidant defense in patients with chronic hepatitis C patients before and after pegylated interferon alfa-2b plus ribavirin therapy
    • Levent G, Ali A, Ahmet A, et al. Oxidative stress and antioxidant defense in patients with chronic hepatitis C patients before and after pegylated interferon alfa-2b plus ribavirin therapy. J Transl Med 2006;4:25.
    • (2006) J Transl Med , vol.4 , pp. 25
    • Levent, G.1    Ali, A.2    Ahmet, A.3
  • 109
    • 77449150552 scopus 로고    scopus 로고
    • Chronic hepatitis C is associated with peripheral rather than hepatic insulin resistance
    • Milner KL, van der Poorten D, Trenell M, et al. Chronic hepatitis C is associated with peripheral rather than hepatic insulin resistance. Gastroenterology 2010;138:932-41.e1-3.
    • (2010) Gastroenterology , vol.138
    • Milner, K.L.1    Van Der Poorten, D.2    Trenell, M.3
  • 110
    • 70349247875 scopus 로고    scopus 로고
    • Sites and mechanisms of insulin resistance in nonobese, nondiabetic patients with chronic hepatitis C
    • Vanni E, Abate ML, Gentilcore E, et al. Sites and mechanisms of insulin resistance in nonobese, nondiabetic patients with chronic hepatitis C. Hepatology 2009;50:697-706.
    • (2009) Hepatology , vol.50 , pp. 697-706
    • Vanni, E.1    Abate, M.L.2    Gentilcore, E.3
  • 111
    • 3242745192 scopus 로고    scopus 로고
    • Effects of rosiglitazone and metformin on liver fat content, hepatic insulin resistance, insulin clearance, and gene expression in adipose tissue in patients with type 2 diabetes
    • DOI 10.2337/diabetes.53.8.2169
    • Tiikkainen M, Häkkinen AM, Korsheninnikova E, et al. Effects of rosiglitazone and metformin on liver fat content, hepatic insulin resistance, insulin clearance, and gene expression in adipose tissue in patients with type 2 diabetes. Diabetes 2004;53:2169-76. (Pubitemid 38970772)
    • (2004) Diabetes , vol.53 , Issue.8 , pp. 2169-2176
    • Tiikkainen, M.1    Hakkinen, A.-M.2    Korsheninnikova, E.3    Nyman, T.4    Makimattila, S.5    Yki-Jarvinen, H.6
  • 114
    • 0031758094 scopus 로고    scopus 로고
    • Search for hepatitis C virus extrahepatic replication sites in patients with acquired immunodeficiency syndrome: Specific detection of negative- Strand viral RNA in various tissues
    • DOI 10.1002/hep.510280531
    • Laskus T, Radkowski M, Wang LF, et al. Search for hepatitis C virus extrahepatic replication sites in patients with acquired immunodeficiency syndrome: specific detection of negative strand viral RNA in various tissues. Hepatology 1998;28:1398-401. (Pubitemid 28493852)
    • (1998) Hepatology , vol.28 , Issue.5 , pp. 1398-1401
    • Laskus, T.1    Radkowski, M.2    Wang, L.-F.U.3    Vargas, H.4    Rakela, J.5
  • 115
    • 77951701962 scopus 로고    scopus 로고
    • Association of metabolic profiles with hepatic fibrosis in chronic hepatitis C patients with genotype 1 or 2 infection
    • Hsu CS, Liu CH, Liu CJ, et al. Association of metabolic profiles with hepatic fibrosis in chronic hepatitis C patients with genotype 1 or 2 infection. J Gastroenterol Hepatol 2010;25:970-7.
    • (2010) J Gastroenterol Hepatol , vol.25 , pp. 970-977
    • Hsu, C.S.1    Liu, C.H.2    Liu, C.J.3
  • 120
    • 51349122296 scopus 로고    scopus 로고
    • Genotype-specific interactions of insulin resistance, steatosis, and fibrosis in chronic hepatitis C
    • Cua IH, Hui JM, Kench JG, et al. Genotype-specific interactions of insulin resistance, steatosis, and fibrosis in chronic hepatitis C. Hepatology 2008;48:723-31.
    • (2008) Hepatology , vol.48 , pp. 723-731
    • Cua, I.H.1    Hui, J.M.2    Kench, J.G.3
  • 121
    • 72549099803 scopus 로고    scopus 로고
    • Insulin resistance and geographical origin: Major predictors of liver fibrosis and response to peginterferon and ribavirin in HCV-4
    • Moucari R, Ripault MP, Martinot-Peignoux M, et al. Insulin resistance and geographical origin: major predictors of liver fibrosis and response to peginterferon and ribavirin in HCV-4. Gut 2009;58:1662-9.
    • (2009) Gut , vol.58 , pp. 1662-1669
    • Moucari, R.1    Ripault, M.P.2    Martinot-Peignoux, M.3
  • 122
    • 67449085321 scopus 로고    scopus 로고
    • Influence of insulin resistance on hepatic fibrosis and steatosis in hepatitis C virus (HCV) mono-infected compared with HIVeHCV co-infected patients
    • Halfon P, Pénaranda G, Carrat F, et al. Influence of insulin resistance on hepatic fibrosis and steatosis in hepatitis C virus (HCV) mono-infected compared with HIVeHCV co-infected patients. Aliment Pharmacol Ther 2009;30:61-70.
    • (2009) Aliment Pharmacol Ther , vol.30 , pp. 61-70
    • Halfon, P.1    Pénaranda, G.2    Carrat, F.3
  • 123
    • 22744435914 scopus 로고    scopus 로고
    • Insulin resistance plays a significant role in liver fibrosis in chronic hepatitis C and in the response to antiviral therapy
    • DOI 10.1111/j.1572-0241.2005.41403.x
    • D'Souza R, Sabin CA, Foster GR. Insulin resistance plays a significant role in liver fibrosis in chronic hepatitis C and in the response to antiviral therapy. Am J Gastroenterol 2005;100:1509-15. (Pubitemid 41032355)
    • (2005) American Journal of Gastroenterology , vol.100 , Issue.7 , pp. 1509-1515
    • D'Souza, R.1    Sabin, C.A.2    Foster, G.R.3
  • 124
    • 77956343048 scopus 로고    scopus 로고
    • Insulin resistance predicts rapid virologic response to peginterferon/ribavirin combination therapy in hepatitis C genotype 4 patients
    • Khattab M, Eslam M, Sharwae MA, et al. Insulin resistance predicts rapid virologic response to peginterferon/ribavirin combination therapy in hepatitis C genotype 4 patients. Am J Gastroenterol. 2010;105:1970-7.
    • (2010) Am J Gastroenterol , vol.105 , pp. 1970-1977
    • Khattab, M.1    Eslam, M.2    Sharwae, M.A.3
  • 125
    • 42449160120 scopus 로고    scopus 로고
    • Insulin resistance impairs rapid virologic response in HIV/hepatitis C virus coinfected patients on peginterferon-alfa-2a
    • DOI 10.1097/QAD.0b013e3282fbd1c4, PII 0000203020080423000008
    • Nasta P, Gatti F, Puoti M, et al. Insulin resistance impairs rapid virologic response in HIV/hepatitis C virus coinfected patients on peginterferon-alfa-2a. AIDS 2008;22:857-61. (Pubitemid 351563835)
    • (2008) AIDS , vol.22 , Issue.7 , pp. 857-861
    • Nasta, P.1    Gatti, F.2    Puoti, M.3    Cologni, G.4    Bergamaschi, V.5    Borghi, F.6    Matti, A.7    Ricci, A.8    Carosi, G.9
  • 126
    • 71549129264 scopus 로고    scopus 로고
    • Insulin resistance predicts rapid virological response in non-diabetic, non-cirrhotic genotype 1 HCV patients treated with peginterferon alpha-2b plus ribavirin
    • Grasso A, Malfatti F, De Leo P, et al. Insulin resistance predicts rapid virological response in non-diabetic, non-cirrhotic genotype 1 HCV patients treated with peginterferon alpha-2b plus ribavirin. J Hepatol 2009;51:984-90.
    • (2009) J Hepatol , vol.51 , pp. 984-990
    • Grasso, A.1    Malfatti, F.2    De Leo, P.3
  • 129
    • 61849108171 scopus 로고    scopus 로고
    • Insulin resistance predicts response to peginterferon-alpha/ribavirin combination therapy in chronic hepatitis C patients
    • Dai CY, Huang JF, Hsieh MY, et al. Insulin resistance predicts response to peginterferon-alpha/ribavirin combination therapy in chronic hepatitis C patients. J Hepatol 2009;50:712-18.
    • (2009) J Hepatol , vol.50 , pp. 712-718
    • Dai, C.Y.1    Huang, J.F.2    Hsieh, M.Y.3
  • 130
    • 74049087081 scopus 로고    scopus 로고
    • Whole-body insulin sensitivity index is a highly specific predictive marker for virological response to peginterferon plus ribavirin therapy in chronic hepatitis C patients with genotype 1b and high viral load
    • Mizuta T, Kawaguchi Y, Eguchi Y, et al. Whole-body insulin sensitivity index is a highly specific predictive marker for virological response to peginterferon plus ribavirin therapy in chronic hepatitis C patients with genotype 1b and high viral load. Dig Dis Sci 2010;55:183-9.
    • (2010) Dig Dis Sci , vol.55 , pp. 183-189
    • Mizuta, T.1    Kawaguchi, Y.2    Eguchi, Y.3
  • 131
    • 57649198713 scopus 로고    scopus 로고
    • Insulin resistance is a major determinant of sustained virological response in genotype 1 chronic hepatitis C patients receiving peginterferon alpha-2b plus ribavirin
    • Chu CJ, Lee SD, Hung TH, et al. Insulin resistance is a major determinant of sustained virological response in genotype 1 chronic hepatitis C patients receiving peginterferon alpha-2b plus ribavirin. Aliment Pharmacol Ther 2009;29:46-54.
    • (2009) Aliment Pharmacol Ther , vol.29 , pp. 46-54
    • Chu, C.J.1    Lee, S.D.2    Hung, T.H.3
  • 132
    • 36549032819 scopus 로고    scopus 로고
    • Insulin resistance and response to therapy in patients infected with chronic hepatitis C virus genotypes 2 and 3
    • DOI 10.1016/j.jhep.2007.07.026, PII S0168827807005089
    • Poustchi H, Negro F, Hui J, et al. Insulin resistance and response to therapy in patients infected with chronic hepatitis C virus genotypes 2 and 3. J Hepatol 2008;48:28-34. (Pubitemid 350191982)
    • (2008) Journal of Hepatology , vol.48 , Issue.1 , pp. 28-34
    • Poustchi, H.1    Negro, F.2    Hui, J.3    Cua, I.H.Y.4    Brandt, L.R.5    Kench, J.G.6    George, J.7
  • 133
    • 84984548367 scopus 로고    scopus 로고
    • Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: A follow-up study in Taiwan
    • Chen CL, Yang HI, Yang WS, et al. Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: a follow-up study in Taiwan. Gastroenterology 2008;135:111-21.
    • (2008) Gastroenterology , vol.135 , pp. 111-121
    • Chen, C.L.1    Yang, H.I.2    Yang, W.S.3
  • 135
    • 15544382574 scopus 로고    scopus 로고
    • Diabetes increases the risk of hepatocellular carcinoma in the United States: A population based case control study
    • DOI 10.1136/gut.2004.052167
    • Davila JA, Morgan RO, Shaib Y, et al. Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study. Gut 2005;54:533-9. (Pubitemid 40403031)
    • (2005) Gut , vol.54 , Issue.4 , pp. 533-539
    • Davila, J.A.1    Morgan, R.O.2    Shaib, Y.3    McGlynn, K.A.4    El-Serag, H.B.5
  • 136
    • 0034881446 scopus 로고    scopus 로고
    • The role of diabetes in hepatocellular carcinoma: A case-control study among United States Veterans
    • DOI 10.1016/S0002-9270(01)02617-X, PII S000292700102617X
    • El-Serag HB, Richardson PA, Everhart JE. The role of diabetes in hepatocellular carcinoma: a case-control study among United States Veterans. Am J Gastroenterol 2001;96:2462-7. (Pubitemid 32769212)
    • (2001) American Journal of Gastroenterology , vol.96 , Issue.8 , pp. 2462-2467
    • El-Serag, H.B.1    Richardson, P.A.2    Everhart, J.E.3
  • 138
    • 67650456227 scopus 로고    scopus 로고
    • The impact of type 2 diabetes on the development of hepatocellular carcinoma in different viral hepatitis statuses
    • Wang CS, Yao WJ, Chang TT, et al. The impact of type 2 diabetes on the development of hepatocellular carcinoma in different viral hepatitis statuses. Cancer Epidemiol Biomarkers Prev 2009;18:2054-60.
    • (2009) Cancer Epidemiol Biomarkers Prev , vol.18 , pp. 2054-2060
    • Wang, C.S.1    Yao, W.J.2    Chang, T.T.3
  • 139
    • 70349232293 scopus 로고    scopus 로고
    • Diabetes pattern on the 75 g oral glucose tolerance test is a risk factor for hepatocellular carcinoma in patients with hepatitis C virus
    • Konishi I, Hiasa Y, Shigematsu S, et al. Diabetes pattern on the 75 g oral glucose tolerance test is a risk factor for hepatocellular carcinoma in patients with hepatitis C virus. Liver Int 2009;29:1194-201.
    • (2009) Liver Int , vol.29 , pp. 1194-1201
    • Konishi, I.1    Hiasa, Y.2    Shigematsu, S.3
  • 140
    • 58949093452 scopus 로고    scopus 로고
    • Insulin resistance is a risk factor for esophageal varices in hepatitis C virus cirrhosis
    • Cammà C, Petta S, Di Marco V, et al. Insulin resistance is a risk factor for esophageal varices in hepatitis C virus cirrhosis. Hepatology 2009;49:195-203.
    • (2009) Hepatology , vol.49 , pp. 195-203
    • Cammà, C.1    Petta, S.2    Di Marco, V.3
  • 141
    • 0035960038 scopus 로고    scopus 로고
    • Posttransplant diabetes mellitus in liver transplant recipients: Risk factors, temporal, relationship with hepatitis C virus allograft hepatitis, and impact on mortality
    • Baid S, Cosimi AB, Farrell ML, et al. Post transplant diabetes mellitus in liver transplant recipients: risk factors, temporal relationship with hepatitis C virus allograft hepatitis, and impact on mortality. Transplantation 2001;72:1066-72. (Pubitemid 32924079)
    • (2001) Transplantation , vol.72 , Issue.6 , pp. 1066-1072
    • Baid, S.1    Cosimi, A.B.2    Lin, F.M.3    Schoenfeld, D.A.4    Feng, S.5    Chung, R.T.6    Tolkoff-Rubin, N.7    Pascual, M.8
  • 142
    • 51349121640 scopus 로고    scopus 로고
    • The significance of metabolic syndrome in the setting of recurrent hepatitis C after liver transplantation
    • Hanouneh IA, Feldstein AE, McCullough AJ, et al. The significance of metabolic syndrome in the setting of recurrent hepatitis C after liver transplantation. Liver Transpl 2008;14:1287-93.
    • (2008) Liver Transpl , vol.14 , pp. 1287-1293
    • Hanouneh, I.A.1    Feldstein, A.E.2    McCullough, A.J.3
  • 144
    • 0036023929 scopus 로고    scopus 로고
    • Outcome of patients with new-onset diabetes mellitus after liver transplantation compared with those without diabetes mellitus
    • John PR, Thuluvath PJ. Outcome of patients with new-onset diabetes mellitus after liver transplantation compared with those without diabetes mellitus. Liver Transpl 2002;8:708-13.
    • (2002) Liver Transpl , vol.8 , pp. 708-713
    • John, P.R.1    Thuluvath, P.J.2
  • 145
    • 66249095118 scopus 로고    scopus 로고
    • Insulin resistance, serum adipokines and risk of fibrosis progression in patients transplanted for hepatitis C
    • Veldt BJ, Poterucha JJ, Watt KD, et al. Insulin resistance, serum adipokines and risk of fibrosis progression in patients transplanted for hepatitis C. Am J Transplant 2009;9:1406-13.
    • (2009) Am J Transplant , vol.9 , pp. 1406-1413
    • Veldt, B.J.1    Poterucha, J.J.2    Watt, K.D.3
  • 147
  • 148
    • 59349094958 scopus 로고    scopus 로고
    • Hepatitis C virus, steatosis and lipid abnormalities: Clinical and pathogenic data
    • Negro F, Sanyal AJ. Hepatitis C virus, steatosis and lipid abnormalities: clinical and pathogenic data. Liver Int 2009;29 (Suppl 2):26-37.
    • (2009) Liver Int , vol.29 , Issue.SUPPL. 2 , pp. 26-37
    • Negro, F.1    Sanyal, A.J.2
  • 149
    • 33645114359 scopus 로고    scopus 로고
    • Non-response to antiviral therapy is associated with obesity and increased hepatic expression of suppressor of cytokine signalling 3 (SOCS-3) in patients with chronic hepatitis C, viral genotype
    • Walsh MJ, Jonsson JR, Richardson MM, et al. Non-response to antiviral therapy is associated with obesity and increased hepatic expression of suppressor of cytokine signalling 3 (SOCS-3) in patients with chronic hepatitis C, viral genotype. Gut 2006;55:529-35.
    • (2006) Gut , vol.55 , pp. 529-535
    • Walsh, M.J.1    Jonsson, J.R.2    Richardson, M.M.3
  • 150
    • 0033636780 scopus 로고    scopus 로고
    • Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob/ob mice
    • Shimomura I, Matsuda M, Hammer RE, et al. Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob/ob mice. Mol Cell 2000;6:77-86.
    • (2000) Mol Cell , vol.6 , pp. 77-86
    • Shimomura, I.1    Matsuda, M.2    Hammer, R.E.3
  • 152
    • 77950610186 scopus 로고    scopus 로고
    • Association of exogenous insulin or sulphonylurea treatment with an increased incidence of hepatoma in patients with hepatitis C virus infection
    • Kawaguchi T, Taniguchi E, Morita Y, et al. Association of exogenous insulin or sulphonylurea treatment with an increased incidence of hepatoma in patients with hepatitis C virus infection. Liver Int 2010;30:479-86.
    • (2010) Liver Int , vol.30 , pp. 479-486
    • Kawaguchi, T.1    Taniguchi, E.2    Morita, Y.3
  • 153
    • 33645819203 scopus 로고    scopus 로고
    • Mechanisms of liver injury. III. Oxidative stress in the pathogenesis of hepatitis C virus
    • Choi J, Ou JH. Mechanisms of liver injury. III. Oxidative stress in the pathogenesis of hepatitis C virus. Am J Physiol Gastrointest Liver Physiol 2006;290:G847-51.
    • (2006) Am J Physiol Gastrointest Liver Physiol , vol.290
    • Choi, J.1    Ou, J.H.2
  • 154
    • 40949109774 scopus 로고    scopus 로고
    • Epidemiology of hepatocellular carcinoma in USA
    • El-Serag HB. Epidemiology of hepatocellular carcinoma in USA. Hepatol Res 2007;37(Suppl 2):S88-94.
    • (2007) Hepatol Res , vol.37 , Issue.SUPPL. 2
    • El-Serag, H.B.1
  • 155
    • 34047175876 scopus 로고    scopus 로고
    • Vascular endothelial dysfunction in cirrhosis
    • DOI 10.1016/j.jhep.2007.02.006, PII S0168827807001201
    • Iwakiri Y, Groszmann RJ. Vascular endothelial dysfunction in cirrhosis. J Hepatol 2007;46:927-34. (Pubitemid 46529052)
    • (2007) Journal of Hepatology , vol.46 , Issue.5 , pp. 927-934
    • Iwakiri, Y.1    Groszmann, R.J.2
  • 157
    • 46349099383 scopus 로고    scopus 로고
    • Pioglitazone in chronic hepatitis C not responding to pegylated interferon alpha and ribavirin
    • Overbeck K, Genné D, Golay A, et al. Pioglitazone in chronic hepatitis C not responding to pegylated interferon alpha and ribavirin. J Hepatol 2008;49:295-8.
    • (2008) J Hepatol , vol.49 , pp. 295-298
    • Overbeck, K.1    Genné, D.2    Golay, A.3
  • 158
    • 67349130279 scopus 로고    scopus 로고
    • Correction of insulin resistance in chronic hepatitis C patients not responding to the standard of care: More questions than answers
    • Negro F. Correction of insulin resistance in chronic hepatitis C patients not responding to the standard of care: more questions than answers. J Hepatol 2009;50:1271-2.
    • (2009) J Hepatol , vol.50 , pp. 1271-1272
    • Negro, F.1
  • 159
    • 60049094719 scopus 로고    scopus 로고
    • Pioglitazone improves early virologic kinetic response to PEG IFN/RBV combination therapy in hepatitis C genotype 1 naïve patients
    • Elgouhari HM, Cesario KB, Lopez R, et al. Pioglitazone improves early virologic kinetic response to PEG IFN/RBV combination therapy in hepatitis C genotype 1 naïve patients. Hepatology 2008;48:383A.
    • (2008) Hepatology , vol.48
    • Elgouhari, H.M.1    Cesario, K.B.2    Lopez, R.3
  • 160
    • 60049101298 scopus 로고    scopus 로고
    • A randomized, double-blind, placebo-controlled study of PPAR gamma agonist pioglitazone given in combination with peginterferon and ribavirin in patients with genotype-1chronic hepatitis C
    • Conjeevaram H, Burant CF, McKenna, et al. A randomized, double-blind, placebo-controlled study of PPAR gamma agonist pioglitazone given in combination with peginterferon and ribavirin in patients with genotype-1chronic hepatitis C. Hepatology 2008;48:384A.
    • (2008) Hepatology , vol.48
    • Conjeevaram, H.1    Burant, C.F.2    McKenna3
  • 161
    • 77950602195 scopus 로고    scopus 로고
    • Pioglitazone improves virological response to peginterferon alpha-2b/ribavirin combination therapy in hepatitis C genotype 4 patients with insulin resistance
    • Khattab M, Emad M, Abdelaleem A, et al. Pioglitazone improves virological response to peginterferon alpha-2b/ribavirin combination therapy in hepatitis C genotype 4 patients with insulin resistance. Liver Int 2010;30:447-54.
    • (2010) Liver Int , vol.30 , pp. 447-454
    • Khattab, M.1    Emad, M.2    Abdelaleem, A.3
  • 162
    • 79960328919 scopus 로고    scopus 로고
    • Virologic and metabolic responses in chronic hepatitis C (CHC) patients with insulin resistance (IR) treated with pioglitazone and peginterferon alpha-2 A plus ribavirin
    • Abstract presented in
    • Harrison S, Hamzeh FM, Lentz E, et al. Virologic and metabolic responses in chronic hepatitis C (CHC) patients with insulin resistance (IR) treated with pioglitazone and peginterferon alpha-2 A plus ribavirin. Abstract presented in EASL Apr 15 2010.
    • EASL Apr 15 2010
    • Harrison, S.1    Hamzeh, F.M.2    Lentz, E.3
  • 163
    • 72549104493 scopus 로고    scopus 로고
    • Treatment of insulin resistance with metformin in naïve genotype 1 chronic hepatitis C patients receiving peginterferon alfa-2a plus ribavirin
    • Romero-Gómez M, Diago M, Andrade RJ, et al. Treatment of insulin resistance with metformin in naïve genotype 1 chronic hepatitis C patients receiving peginterferon alfa-2a plus ribavirin. Hepatology 2009;50:1702-8.
    • (2009) Hepatology , vol.50 , pp. 1702-1708
    • Romero-Gómez, M.1    Diago, M.2    Andrade, R.J.3
  • 164
    • 77953553818 scopus 로고    scopus 로고
    • Hyperinsulinaemia reduces the 24-h virological response to PEG-interferon therapy in patients with chronic hepatitis C and insulin resistance
    • Bortoletto G, Scribano L, Realdon S, et al. Hyperinsulinaemia reduces the 24-h virological response to PEG-interferon therapy in patients with chronic hepatitis C and insulin resistance. J Viral Hepat 2010;17:475-80.
    • (2010) J Viral Hepat , vol.17 , pp. 475-480
    • Bortoletto, G.1    Scribano, L.2    Realdon, S.3
  • 166
    • 1242340436 scopus 로고    scopus 로고
    • Modest weight loss and physical activity in overweight patients with chronic liver disease results in sustained improvements in alanine aminotransferase, fasting insulin, and quality of life
    • DOI 10.1136/gut.2003.027581
    • Hickman IJ, Jonsson JR, Prins JB, et al. Modest weight loss and physical activity in overweight patients with chronic liver disease results in sustained improvements in alanine aminotransferase, fasting insulin, and quality of life. Gut 2004;53:413-19. (Pubitemid 38241340)
    • (2004) Gut , vol.53 , Issue.3 , pp. 413-419
    • Hickman, I.J.1    Jonsson, J.R.2    Prins, J.B.3    Ash, S.4    Purdie, D.M.5    Clouston, A.D.6    Powell, E.E.7
  • 167
    • 33645129025 scopus 로고    scopus 로고
    • Does a lower insulin resistance affect antiviral therapy response in patients suffering from HCV related chronic hepatitis?
    • Tarantino G, Conca P, Ariello M, et al. Does a lower insulin resistance affect antiviral therapy response in patients suffering from HCV related chronic hepatitis? Gut 2006;55:585.
    • (2006) Gut , vol.55 , pp. 585
    • Tarantino, G.1    Conca, P.2    Ariello, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.